ZERO - The Project to End Prostate Cancer
ABOUT PROSTATE CANCERGET INVOLVEDPROGRAMSRESEARCHPARTNERSSTOREABOUT US
Risk Factors
Prevention
Detection
Diagnosis
Treatment
New Prostate Cancer Research
Prostate Cancer Resources
Managing Bone Metastases and Pain
Side Effects of Prostate Cancer Treatment

Dogs Sniff Out Prostate Cancer

Approach associated with few false positives in early testing

by Charlene Laino | WebMD.com | 06.02.2010

Dogs may be able to sniff out the smell of chemicals released into urine by prostate tumors, setting the stage for a new means of early prostate cancer detection.

In early tests, the approach produced fewer false positives than would be expected with the commonly used PSA test, French researchers report.

The concept isn't new. Other researchers have reported varying degrees of success using dogs to detect cancers of the skin, lung, and bladder, says researcher Pierre Bigot, MD, of Tenon Hospital in Paris.

The theory is that many tumors release chemicals with distinct odors that can be picked up by dogs, whose sense of smell is much more sensitive than that of humans, he tells WebMD.

Better Prostate Cancer Tests Needed
More accurate prostate cancer tests are sorely needed, says Anthony Y. Smith, MD, chief of urology at the University of New Mexico in Albuquerque.

While the widely used PSA test picks up a lot of cancers, it also has a high false-positive rate, he tells WebMD.

"If all the men with high PSA scores go on to have biopsies, fewer than one-third will actually have cancer," Smith says.

Plus, many men with early prostate cancer are unnecessarily treated because existing tests can't distinguish between life-threatening and slow-growing tumors, he says.

In the United States, one man in six will receive a diagnosis of prostate cancer during his lifetime, but a much smaller proportion -- one in 35 -- will die from the disease, according to the American Cancer Society.

Smith moderated a news briefing on the findings at the American Urological Association annual meeting.

Dogs Sniff Out 63 of 66 Prostate Cancer Samples
For the new study, researchers led by Jean-Nicolas Cornu, MD, also of Tenon Hospital, trained a Belgian Malinois -- a shepherd breed used for detecting bombs and drugs -- to identify urine from patients with confirmed prostate cancer and then to discriminate those samples from urine from healthy men.

After about a year of training, the dog was put to the test. During 11 runs, the dog faced six urine samples, only one of which came from a man with prostate cancer. Its mission: To sit in front of the urine it considers cancer.

In 66 tests, the dog was correct 63 times. There were three false positives, in which the dog mistakenly identified samples from healthy men as being cancerous. And there were no false negatives.

And one of the three false positives might not have been that false; when the man who provided the urine sample had another biopsy, he turned out to have prostate cancer, Bigot says.

Other dogs are now being trained, he says.

'Electronic Nose' for Prostate Cancer Detection
The low false-positive rate "is pretty spectacular," Smith says.

"But this is a very small study," and it remains to be seen if the findings will hold up in other studies, he says.

Skeptics are concerned that the animals may be picking up on subconscious signals from researchers, among other things, Smith says.

The next step is to figure out what chemicals or combination of chemicals the dog is sensing, he says.

If the approach does pan out, don't look for dogs running around hospitals, sniffing urine samples. That would be impractical and prohibitively expensive, Bigot says.

But if researchers can identify which chemical the dog is reacting to, they hope to develop an "electronic nose" for more accurate prostate cancer detection, he says.

 Copyright WebMD 2010

 

 

All active news articles
About Prostate Cancer  |  Donate  |  Get Involved  |  Programs  |  Research   |  Partners  |  Store  |  About Us  |  Site Map  |  Contact Us  |  Privacy PolicySubscribe to the ZERO Prostate Cancer News Feed  

© Copyright 2010, ZERO - The Project to End Prostate Cancer. All rights reserved.

ZERO does not endorse any course of treatment for men with prostate cancer or other conditions. Treatment decisions should be made by a patient and his health
service provider. If you have problems with the site or need more information, please call us at 1.888.245.9455 or e-mail your comments. All names, logos and articles
are the copyrights of the respective owners.